Looniewell

A proactive approach to your health with preferred rates at Medcan

You
are
eligible
for
preferred
rates

As a Looniewell client, you can benefit from preferred rates on a suite of services from Medcan, a global leader in proactive health and personalized care. This includes the Annual Health Assessment, a physician-led full-body evaluation of 100+ biomarkers, as well as ongoing care memberships and the Galleri® multi-cancer early detection test. Complete the form and your dedicated contact will contact you to book the services of your choice.

More details on the services offered can be found below.

Couple biking through forest

Annual
Health
Assessment

With over 100 biomarkers evaluated across 15 specialized stations in a single-day visit, this comprehensive assessment delivers deep insights into every aspect of your health to identify risk factors and provide personalized recommendations.

Through your assessment and physician consultation, you will leave with a complete picture of your health and comprehensive plan to achieve your goals.

If any health concerns arise during your assessment, you will be referred to a specialist for a follow-up, if required. The full details of your assessment will be made available to you through our secure portal, myMedcan, for you to reference any time and take action.

You can enhance your Annual Health Assessment and explore specific areas of concern you may have. In advance of your appointment, you will have the opportunity to add one or more enhanced screenings to your day, including the Galleri® multi-cancer early detection test. These enhanced assessments provide greater insight into your liver and heart health, cancer risk, genetics and gender-specific concerns.

Additional
Medcan
Services

The Galleri test by GRAIL sets the standard for multi-cancer early detection and is ideal for those who are seeking a more comprehensive proactive approach to cancer screening. 

Through a single blood draw, this innovative, clinically validated test screens for 50+ cancer types, like pancreatic and ovarian before they become symptomatic, maximizing the opportunity for early diagnosis, when treatment can be most effective. 

Medcan provides support throughout the testing process, with an optional pre-test consultation available for those who have questions about whether this test is right for them.

Gain more control over your health with the right level of support. Our ongoing care memberships offer convenient and accessible care, virtually and in-person, with same or next-day appointments. Year-Round Care is designed to address minor illnesses and injuries without the hassle of long lines and crowded waiting rooms. Dedicated Care provides you with your own primary care physician for greater personalization and continuity of care. M Care is a premium, concierge-level of care with a direct line of contact to your dedicated physician who can provide home or office visits along with after-hours and weekend availability.

Benefit from a suite of genetic screening offerings which providing greater health insights through detailed genetic screening with guidance from a certified genetic counsellor. Services include Medication Effectiveness Screening, Heart Health Screening or Cancer Prevention Screening, and Whole Genome Sequencing

Galleri is a registered trademark of GRAIL, Inc. 

*The Galleri test does not detect a signal for all cancers. Not all cancers can be detected in the blood. False positive and false negative results do occur. 1 in 100 can expect to receive a CSD result, and approximately 60% of these individuals will receive a confirmed cancer diagnosis. The overall sensitivity in study participants with head and neck cancer was 85.7% (63.2% for stage I, 82.4% stage II, 84.2% stage III, 96.0% stage IV). 

Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. The Galleri test is not a genetic risk assessment and does not predict future genetic risk for cancer. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false/negative results do occur. Galleri should be used in addition to healthcare provider recommended screening tests.

Important Safety Information: The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment. Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer. If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur.

Lab / Test information: The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. This test is not Health Canada or FDA approved, and has not been endorsed by any professional medical societies at this time. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.